跳至主要内容
临床试验/NCT04955951
NCT04955951终止不适用

Ultrasonographic Response to Polarized Light Therapy in the Treatment of Atopic Dermatitis

Ahram Canadian University1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2021年7月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
终止
入组人数
40
试验地点
1
主要终点
Ultrasonography

研究概览

简要总结

Non-atopic dermatitis (NAD) or eczema is a common inflammatory condition; potentially debilitating that can compromise quality of life. It is usually seen in childhood, but can onset within or persist into adulthood.

详细描述

Polarized ultraviolet-free polychromatic light is used as therapeutic option for the treatment of wound healing and dermatological conditions.

40 male patients who had atopic dermatitis in the chronic stage, they were complaining from itching, inflammation and skin thickness in the arm, wrist, hand and leg will participate in this study.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
20 Years 至 30 Years(Adult)
性别
Male
接受健康志愿者

入选标准

  • The patients' ages will ranged from 20 to 30 years.
  • The subjects will be males.
  • The duration of disease less than 1 year.

排除标准

  • patients who had skin malignancy in the area to be treated.
  • The patients who had history of diabetes, circulatory or sensory disorders.
  • Patients with acute infection in the area treated.

研究组 & 干预措施

polarized light group

group A (20 patients) will receive Polarized light therapy

干预措施: polarized light (Device)

topical corticosteroid group

group B (20 patients) will receive topical corticosteroid therapy

干预措施: Topical corticosteroid ointment (Drug)

结局指标

主要结局

Ultrasonography

时间窗: 1-2 months

Ultrasound imaging system used to measure the thickness of the skin at the site of scale for both groups

次要结局

  • SCORAD Score(1-2 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mahmoud H Mohamed, PhD

LECTURER

Ahram Canadian University

研究点 (1)

Loading locations...

相似试验